- Home
- MRUS vs PJT Comparison
MRUS vs PJT Comparison
Compare MRUS & PJT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRUS
- PJT
- Stock Information
- Founded
- MRUS 2003
- PJT 2014
- Country
- MRUS Netherlands
- PJT United States
- Employees
- MRUS N/A
- PJT N/A
- Industry
- MRUS Biotechnology: Pharmaceutical Preparations
- PJT Investment Managers
- Sector
- MRUS Health Care
- PJT Finance
- Exchange
- MRUS Nasdaq
- PJT Nasdaq
- Market Cap
- MRUS 5.1B
- PJT 4.4B
- IPO Year
- MRUS 2016
- PJT N/A
- Fundamental
- Price
- MRUS $94.81
- PJT $168.89
- Analyst Decision
- MRUS Buy
- PJT Hold
- Analyst Count
- MRUS 18
- PJT 3
- Target Price
- MRUS $93.72
- PJT $192.50
- AVG Volume (30 Days)
- MRUS 2.6M
- PJT 216.3K
- Earning Date
- MRUS 10-31-2025
- PJT 11-04-2025
- Dividend Yield
- MRUS N/A
- PJT 0.59%
- EPS Growth
- MRUS N/A
- PJT 54.67
- EPS
- MRUS N/A
- PJT 5.83
- Revenue
- MRUS $56,228,000.00
- PJT $1,537,018,000.00
- Revenue This Year
- MRUS $51.77
- PJT $11.16
- Revenue Next Year
- MRUS N/A
- PJT $12.76
- P/E Ratio
- MRUS N/A
- PJT $28.96
- Revenue Growth
- MRUS 59.77
- PJT 18.48
- 52 Week Low
- MRUS $33.19
- PJT $119.76
- 52 Week High
- MRUS $95.30
- PJT $190.28
- Technical
- Relative Strength Index (RSI)
- MRUS 79.21
- PJT 37.61
- Support Level
- MRUS $94.59
- PJT $174.52
- Resistance Level
- MRUS $95.06
- PJT $185.67
- Average True Range (ATR)
- MRUS 0.36
- PJT 4.30
- MACD
- MRUS -1.00
- PJT 0.05
- Stochastic Oscillator
- MRUS 47.87
- PJT 10.08
About MRUS Merus N.V.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.
About PJT PJT Partners Inc.
PJT Partners Inc is an advisory-focused investment bank that offers a portfolio of advisory services designed to help its clients achieve their strategic objectives. The company delivers a range of strategic advisory, capital markets advisory, restructuring and special situations, and shareholder advisory services to corporations, financial sponsors, institutional investors, and governments around the world. It also provides private fund advisory and fundraising services for alternative investment strategies, including private equity, real estate, hedge funds, and private credit. The company generates its revenue from advisory fees, placement services and others. Geographically, It generates a majority of its revenue from the United States.